ACADIA Pharmaceuticals (ACAD) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ACAD ACADIA Pharmaceuticals

Watchlist

17.260
0.0000.00%

Close Dec 13 16:00 ET

18.430
+1.170+6.78%

Post 18:21 ET

2.87BMarket Cap22.13P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | ACADIA Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
ReutersDec 11 16:05 ET
Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
BusinesswireDec 11 16:05 ET
Express News | ACADIA Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer
ReutersDec 9 09:00 ET
Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer
BusinesswireDec 9 09:00 ET
Why Acadia Pharmaceuticals (ACAD) Is a Top Momentum Stock for the Long-Term
Yahoo FinanceDec 3 09:50 ET
Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options
Zacks Dec 3 07:35 ET

Comments

Trytosaveabit

Dec 11 15:06

News

$ACADIA Pharmaceuticals (ACAD.US)$ Reuters· 1 min ago
ACADIA Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million

Jaguar8

Nov 26 23:04

My Wednesday Watchlist. Trade the chart. Do not be impulsive. 11 stocks on watchlist today ran.

$HWH International (HWH.US)$ 13D 88.9%. China stock. Low float. SI 214%✅
$Infobird Software (IFBD.US)$ Completed $40M acquisition. China stock. Low float. 0 shares LTB✅
$Ocean Power Technologies (OPTT.US)$ Form 4 insider buying. 0 shares LTB✅
$T Stamp (IDAI.US)$ Ran today. Up after hours. Possible catalyst. Low float. 0 shares LTB✅
$Syra Health (SYRA.US)$ Recent Form 4s multiple insider loading. Low fl...

Jaguar8

Nov 26 15:13

NEWS

$ACADIA Pharmaceuticals (ACAD.US)$
Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711
Acadia Pharmaceuticals (NASDAQ: ACAD) has secured an exclusive worldwide license agreement with Saniona for SAN711, a first-in-class GABAA-α3 positive allosteric modulator.
The company plans to develop SAN711 for essential tremor treatment, with Phase 2 studies expected to begin in 2026. Under the agreement, Saniona will receive a $28 million upfront payment plus potential ...

Trytosaveabit

Nov 26 15:08

News

$ACADIA Pharmaceuticals (ACAD.US)$ Reuters· 1 min ago
ACADIA Pharmaceuticals Inc - Saniona to Receive $28 Million Upfront Plus up to $582 Million in Milestones with exclusive licensing agreement with Saniona for San711

Trytosaveabit

Nov 5 15:06

News

$ACADIA Pharmaceuticals (ACAD.US)$ Reuters· just
ACADIA Pharmaceuticals Enters Into an Agreement to Sell Its Rare Pediatric Disease Priority Review Voucher for $150 Million

Heat List

Overall

No Data